MARATTO

article · Russian Journal of Organic Chemistry

Design, Green Synthesis, and Anticancer Activity of Novel Nicotinonitrile Derivatives

20248 citationsAin Shams University

Abstract

Novel pyridine derivatives were successfully synthesized by grinding, microwave-assisted, and conventional techniques. Ethyl 6-amino-5-cyano-2-methyl-4-[(1S,2R,3R,4R)-1,2,3,4,5-pentahydroxypentyl]nicotinate (1) was synthesized and used as a versatile reagent for the synthesis of novel compounds such as nicotinic acid, nicotinohydrazide, 3,5-dioxopyrazolidine, 1,2,4-triazole, cyanoacetamide, urea, 2,5-dioxopyrrolidine, 3-dioxoisoindoline, sulfonamide, Schiff base, and formamide derivatives by its reactions with a series of nucleophilic and electrophilic reagents. The results of the synthesis with the use of the grinding, microwave, and conventional techniques were compared. The structures and compositions of the newly synthesized compounds were confirmed by IR and 1H and 13C NMR spectroscopy, mass spectrometry, and elemental analysis. Some of the synthesized compounds were screened in vitro for the activity against two cancer cell lines. Ethyl 5-cyano-2-methyl-4-[(1S,2R,3R,4R)-1,2,3,4,5-pentahydroxypentyl]-6-(3-phenylureido)nicotinate showed a high cytotoxic activity and selectivity against cancer cells (HePG2: IC50 = 34.31 μM; Caco-2: IC50 = 24.79 μM). Imaging cancer cell lines treated by some synthesized compounds was performed by transmission electron microscopy.

Research topics

  • Synthesis and Characterization of Heterocyclic Compounds
  • Synthesis and biological activity
  • Bioactive Compounds and Antitumor Agents

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1134/s1070428024020167

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.